Article abstract


Nature Immunology 8, 1390 - 1397 (2007)
Published online: 11 November 2007 | doi:10.1038/ni1539

TGF-bold beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology

Mandy J McGeachy1, Kristian S Bak-Jensen1, Yi Chen1, Cristina M Tato1, Wendy Blumenschein1, Terrill McClanahan1 & Daniel J Cua1


Studies have shown that transforming growth factor-beta (TGF-beta) and interleukin 6 (IL-6) are required for the lineage commitment of pathogenic IL-17-producing T helper cells (TH-17 cells). Unexpectedly, here we found that stimulation of myelin-reactive T cells with TGF-beta plus IL-6 completely abrogated their pathogenic function despite upregulation of IL-17 production. Cells stimulated with TGF-beta plus IL-6 were present in the spleen as well as the central nervous system, but they failed to upregulate the proinflammatory chemokines crucial for central nervous system inflammation. In addition, these cells produced IL-10, which has potent anti-inflammatory activities. In contrast, stimulation with IL-23 promoted expression of IL-17 and proinflammatory chemokines but not IL-10. Hence, TGF-beta and IL-6 'drive' initial lineage commitment but also 'restrain' the pathogenic potential of TH-17 cells. Our findings suggest that full acquisition of pathogenic function by effector TH-17 cells is mediated by IL-23 rather than by TGF-beta and IL-6.

Top
  1. Schering-Plough Biopharma, Palo Alto, California 94304, USA.

Correspondence to: Daniel J Cua1 e-mail: daniel.cua@dnax.org



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Immunology Narcissistic helpers

Nature News and Views (26 Jul 2007)

T effectors outfox T regulators in autoimmunity

Nature Medicine News and Views (01 Apr 2007)

See all 6 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

naturejobs

natureproducts


ADVERTISEMENT